PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators

The Prostate ◽  
2009 ◽  
Vol 70 (2) ◽  
pp. 135-146 ◽  
Author(s):  
P.W. van Duijn ◽  
A.C.J. Ziel-van der Made ◽  
J.A.G. van der Korput ◽  
J. Trapman
Oncogene ◽  
2001 ◽  
Vol 20 (23) ◽  
pp. 2927-2936 ◽  
Author(s):  
Sreenivasa R Chinni ◽  
Yiwei Li ◽  
Sunil Upadhyay ◽  
Prathima K Koppolu ◽  
Fazlul H Sarkar

2013 ◽  
Vol 337 (2) ◽  
pp. 177-183 ◽  
Author(s):  
Thippeswamy Gulappa ◽  
Ramadevi Subramani Reddy ◽  
Suman Suman ◽  
Alice M. Nyakeriga ◽  
Chendil Damodaran

2017 ◽  
Vol 51 (1) ◽  
pp. 51-58 ◽  
Author(s):  
Ibrahim Turan ◽  
Selim Demir ◽  
Kagan Kilinc ◽  
Yuksel Aliyazicioglu ◽  
Ahmet Alver ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (55) ◽  
pp. 44022-44030 ◽  
Author(s):  
L. M. Saeed ◽  
M. Mahmood ◽  
Y. Xu ◽  
Z. A. Nima ◽  
G. K. Kannarpady ◽  
...  

Graphene was used to deliver gambogic acid to cervical, ovarian, and prostate cancer cells and the complex was shown to be more effective at inhibiting cell proliferation, initiating cell cycle arrest and inducing apoptosis compared to the drug alone.


Oncotarget ◽  
2017 ◽  
Vol 9 (13) ◽  
pp. 10962-10977 ◽  
Author(s):  
David W. McIlwain ◽  
Melissa L. Fishel ◽  
Alexander Boos ◽  
Mark R. Kelley ◽  
Travis J. Jerde

Sign in / Sign up

Export Citation Format

Share Document